# Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department

> **NCT02365272** · PHASE4 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 100 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Amikacin

## Key facts

- **NCT ID:** NCT02365272
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365272, "Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02365272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*